Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Use only products specifically formulated for periorbital use, or dilute standard serums significantly
Sikiric is named on BPC-157-related patent applications dating back to at least 1989, and Croatian government records list Predrag Sikiric as an owner of PharmaCotherapia, the company that sponsored the Tijuana trial
The regulatory landscape for injectable GHK-Cu is less defined
The study further elucidated the signaling pathway involved, showing that BPC 157 enhanced the phosphorylation of Src, Caveolin-1 (Cav-1), and endothelial nitric oxide synthase (eNOS)
It upregulates genes involved in tissue remodeling, like collagen I and III production, while downregulating pro-inflammatory pathways like NF-B
The optimal dosing, administration route, and cycling protocol for humans remain uncertain
US$ 27.25
US$ 28.82
US$ 24.19
US$ 24.69
US$ 28.69
US$ 29.52
US$ 29.68
